Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai MicroPort Endovascular MedTech Co., Ltd.
  6. Summary
    688016   CNE100003MJ5

SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.

(688016)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
239 240 238.71 240.62 242.07 Last
1124425 583794 654446 625829 721674 Volume
-2.93% +0.42% -0.54% +0.80% +0.60% Change
Estimated financial data (e)
Sales 2021 677 M 106 M 106 M
Net income 2021 302 M 47,3 M 47,3 M
Net cash position 2021 1 169 M 183 M 183 M
P/E ratio 2021 57,7x
Yield 2021 0,64%
Sales 2022 934 M 146 M 146 M
Net income 2022 414 M 64,9 M 64,9 M
Net cash position 2022 1 378 M 216 M 216 M
P/E ratio 2022 41,9x
Yield 2022 0,75%
Capitalization 17 424 M 2 729 M 2 729 M
EV / Sales 2021 24,0x
EV / Sales 2022 17,2x
Nbr of Employees 591
Free-Float 45,1%
More Financials
Company
Shanghai MicroPort Endovascular MedTech Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral... 
More about the company
Ratings of Shanghai MicroPort Endovascular MedTech Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
08/25Shanghai MicroPort Endovascular MedTech Co., Ltd. Announces Unaudited Financial Results..
CI
08/25Shanghai Microport Endovascular Medtech Co., Ltd. Reports Earnings Results for the Half..
CI
07/20SHANGHAI MICROPORT ENDOVASCULAR MEDT : Sees Up to 56% Surge in H1 Profit; Shares Tumble 10..
MT
07/19Shanghai Microport Endovascular Medtech Co., Ltd. Provides Earnings Guidance for the Si..
CI
04/20Shanghai Microport Endovascular Medtech Co., Ltd. Reports Earnings Results for the Firs..
CI
03/29Shanghai Microport Endovascular Medtech Co., Ltd. Reports Earnings Results for the Full..
CI
01/25Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Ye..
CI
2020SHANGHAI MICROPORT ENDOVASCULAR MEDT : 688016) added to Shanghai Stock Exchange Health Car..
CI
2020Shanghai Hongmai Medical Technology Co., Ltd. announced that it expects to receive fund..
CI
2020Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Unaudited Earnings Results fo..
CI
2020Shanghai Microport Endovascular Medtech Co., Ltd. Announces Earnings Results for the Fi..
CI
2020Certain A Shares of Shanghai MicroPort Endovascular MedTech Co., Ltd. are subject to a ..
CI
2020Shanghai Microport Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Si..
CI
2020Shanghai Lanmai Medical Technology Co., Ltd. announced that it expects to receive CNY 6..
CI
2020Shanghai Microport Endovascular Medtech Co., Ltd. Declares Cash Dividend Per A Share fo..
CI
More news
News in other languages on SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.

- No features available -

More news
Chart SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Duration : Period :
Shanghai MicroPort Endovascular MedTech Co., Ltd. Technical Analysis Chart | 688016 | CNE100003MJ5 | MarketScreener
Technical analysis trends SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 242,07 CNY
Average target price 437,00 CNY
Spread / Average Target 80,5%
EPS Revisions
Managers and Directors
Qing Zhu General Manager & Director
Jian Hua Gu Chief Financial Officer & Board Secretary
Bo Peng Chairman
Cheng Yun Yue Chairman-Supervisory Board
Hai Bing Wu Independent Director
Sector and Competitors